Deerfield Management Company, L.P. (Series C) Ptc Therapeutics, Inc. Transaction History

Deerfield Management Company, L.P. (Series C)

$5.38 Billion
Q3 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$32.22 - $50.07 $15.2 Million - $23.6 Million	-471,000 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$35.42 - $45.0 $8.29 Million - $10.5 Million	234,000 Added 98.73%	471,000 $21.2 Million
Q1 2019 May 15, 2019	BUY	$28.09 - $39.49 $6.66 Million - $9.36 Million	237,000 New	237,000 $8.92 Million

Others Institutions Holding PTCT

# of Institutions

223

Shares Held

78.1M

Call Options Held

144K

Put Options Held

58.7K

Vanguard Group Inc Valley Forge, PA

9.13M
Shares

$387 Million
0.01% of portfolio
Wellington Management Group LLP Boston, MA

7.89M
Shares

$334 Million
0.05% of portfolio
Black Rock Inc. New York, NY

7.77M
Shares

$329 Million
0.01% of portfolio
Rtw Investments, LP New York, NY

7.39M
Shares

$313 Million
4.37% of portfolio
Armistice Capital, LLC New York, NY

7.23M
Shares

$307 Million
4.46% of portfolio

View Full List

About PTC THERAPEUTICS, INC.

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $3.03B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

More about PTCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deerfield Management Company, L.P. (Series C), based on Form 13F filings with the SEC.

News

Stay updated on Deerfield Management Company, L.P. (Series C) with notifications on news.

Account